Greeting from the Director
Tohoku University established the Tohoku University Biomedical Engineering Research Organization (TUBERO) in 2003 with the objective of R&D centering on medical engineering. In 2007 the Innovation of New Biomedical Engineering Center (INBEC) was established as the succeeding organization of TUBERO, and in 2012 by developmentally integrating it with the Tohoku University Hospital Clinical Research Center, the Clinical Research, Innovation and Education Center, Tohoku University Hospital (CRIETO) was established. Currently, CRIETO is a comprehensive research center equipped with the requisite support system for the creation of new medical devices and drugs.
Each of CRIETO’s departments exercise their special expertise to take charge of the development of medical devices and drugs through their various phases, and in conjunction with the other departments organically and efficiently realize the research seeds of academic researchers. CRIETO itself contributes to the promotion of the clinical research conducted at Tohoku University Hospital such as Clinical Research Core Hospital projects, and eagerly adopt basic seeds in collaboration with the Tohoku University School of Medicine. Furthermore, through the development of medical devices and drugs, we serve as the center of industry-academia collaboration at Tohoku University and expand these activities.
Due to the development and application of AI and the progress in molecular biology, the speed with which drugs and medical devices are being developed is increasing each year, and their globalization is also becoming more prominent. In addition, there is a strong need for collaboration across a wide range of fields, not only medicine, in order to develop new drugs and medical devices. Given these circumstances, it is quite certain that the presence of academia with basic seeds and the ability to enter into interdisciplinary collaboration with other fields will become ever more important. However, translating academic research into its final shape is not merely a question of gathering seeds; it is vital to support researchers from clinical research and testing phases to achievement of exit strategy goals. This is exactly where CRIETOs mission lies.
In order to provide patients suffering from diseases with new treatment options, CRIETO will realize as many as possible academic seeds and deliver them to the medical practice sites. Your kind understanding and cooperation for CRIETO will be greatly appreciated.
Professor, Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine